Award

Purchase Order #75N98026P00521

Proteomic Analysis Service Contract Awarded to Psomagen Inc for Sickle Cell Study

Buyer

National Institutes of Health

Award Amount

$199,994.72

Ceiling

$199,994.72

Awarded

May 14, 2026

Period of Performance

May 14, 2026 – Nov 21, 2026

Identifier

75N98026P00521

NAICS

541380

This award represents a purchase order contract awarded to Psomagen Inc, a company specializing in advanced genomic and proteomic services. The contract procures high-throughput proteomic analysis services using the Olink Explore HT platform to support a sickle cell disease study under the National Heart, Lung, and Blood Institute (NHLBI). This specialized service is critical for advancing biomedical research on sickle cell disease, facilitating the identification of protein biomarkers essential for understanding disease mechanisms. The work involves detailed analysis of biological samples to generate comprehensive proteomic data. Awarded through a competitive process, this agreement reflects the importance of precision proteomic tools in health research. The contract covers performance during a defined multi-month period, ensuring timely delivery of the analytical results. The work is performed at Rockville, Maryland, supporting NASA-related or NIH-centered research efforts. While no subcontractors or prior contracts are reported, the focused timeline and service specification highlight the importance of this procurement for ongoing disease research initiatives.

Description

NHLBI: SERVICE: OLINK EXPLORE HT PROTEOMIC ANALYSIS FOR SICKLE CELL DISEASE STUDY: SEVERABLE

View original record